EDURANT is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Janssen Products, Lp. The primary component is Rilpivirine Hydrochloride.
| Product ID | 59676-278_0823bccc-f79a-400b-a8bf-8e0988f7a158 |
| NDC | 59676-278 |
| Product Type | Human Prescription Drug |
| Proprietary Name | EDURANT |
| Generic Name | Rilpivirine Hydrochloride |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2011-05-20 |
| Marketing Category | NDA / NDA |
| Application Number | NDA202022 |
| Labeler Name | Janssen Products, LP |
| Substance Name | RILPIVIRINE HYDROCHLORIDE |
| Active Ingredient Strength | 25 mg/1 |
| Pharm Classes | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2011-05-20 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA202022 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-05-20 |
| Ingredient | Strength |
|---|---|
| RILPIVIRINE HYDROCHLORIDE | 25 mg/1 |
| SPL SET ID: | 03880372-2c68-45c6-a53a-f420c49541d6 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() EDURANT 85185858 not registered Dead/Abandoned |
JOHNSON & JOHNSON 2010-11-29 |
![]() EDURANT 85125575 4013848 Live/Registered |
JOHNSON & JOHNSON 2010-09-09 |
![]() EDURANT 76647698 not registered Dead/Abandoned |
JOHNSON & JOHNSON 2005-09-29 |